0 New antibody test for SARS-CoV-2
A new SARS-CoV-2 antibody test has been developed with improved accuracy and higher sample throughput at a lower cost in…
Browsing: Clinical > Vaccines
0 In Focus: studying the COVID-19 pandemic – a Special Focus Issue
Infectious Diseases Hub has partnered with Future Virology to bring you exclusive access to articles and features in the recent Special Focus Issue.
0 AstraZeneca COVID-19 vaccine trial resumed in the UK after safety evaluation
AstraZeneca and Oxford University (UK) have resumed the progress of their Phase III COVID-19 vaccine trial after investigating unexpected side effects in a patient enrolled in the trial in the UK.
0 Cytokine storm could sabotage long-term immunity against SARS-CoV-2
COVID-19 patients who develop a cytokine storm in response to infection could be unable to produce memory cells that provide long-term protection against SARS-CoV-2.
0 Countries with previous TB vaccine coverage show improved COVID-19 outcomes
An epidemiological study has revealed that COVID-19 outcomes are better in those countries that have undertaken a TB vaccination regime in the last 15 years.
0 COVID-19: an update on clinical disease, immunology, masking, treatments and virology
An update on the state of knowledge on the COVID-19 pandemic and how this pertains to health including the influence on antiviral strategies to stop the spread of the virus and potential treatments for the disease.
0 Oxford vaccine gives strong immune response against COVID-19
The Oxford vaccine, ChAdOx1 nCoV-19, has demonstrated strong immune responses to COVID-19 in patients, as well as a good safety profile, as the results of the Phase I/II trial are published.
0 Antiviral strategies for emerging infectious diseases: Cayman Chemical
The emergence and global spread of SARS-CoV-2 has prompted scientific study on an unprecedented scale, with an urgent need for…
0 Confronting COVID-19 head on at the Wyss Institute
Harvard’s Wyss Institute is leveraging its unique technology innovation capabilities to develop diagnostic, therapeutic, and vaccine interventions for COVID-19 at lightning speed.
0 Novel adjuvant helps extend immunity against HIV in primates
Researchers at the Emory Vaccine Center have demonstrated that a novel adjuvant, 3M-052, can aid long-lasting immunity against HIV in rhesus monkeys. This could have implications for developing successful vaccines against HIV, influenza and COVID-19.
